Screening Studies of the Antimicrobial Activity of the Pyrimidine Compound 2,2-[6-Bromo-2,4-Dioxoquinazoline-1,3(2H)diyl]bis(N-Carbamimidoylacetamide)

The aim of this study was to screen the antimicrobial activity of a pyrimidine compound under the laboratory code VMA-21-01. Antimicrobial activity was studied in relation to: Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumonia, and Proteus mirabilis. The antimicrobial activity of 2,2-[6-Bromo-2,4-dioxoquinazoline- 1,3(2H)diyl]bis(N-carbamimidoylacetamide) was carried out in vitro by serial dilution and determination of its minimum inhibitory concentration. The sensitivity of microorganisms to the test substance was determined in a meat-peptone broth (visual assessment), followed by reinoculation on meat-peptone agar and colony count. DMSO tubes were used as a control. A 4% gentamicin solution was used as a comparison drug. In an in vitro experiment, it was found that the pyrimidine compound 2,2-[6-Bromo-2,4-dioxyquinazoline-1,3(2H)diyl]bis(N-carbamimidoylacetamide) under the laboratory cipher VMA21-01 has bactericidal activity against K. pneumonia comparable to the comparison drug gentamicin, as well as bacteriostatic activity against S. aureus, S. pneumoniae, E. coli, and P. mirabilis. 

1. Frieri M., Kumar K., Butin A. Antibiotic resistance. J Infect Public Health. 2017; 10 (4): 369–378. doi: 10.1016/j.jiph.2016.08.007.

2. Jamal A. Antibiotics in modern medicine: achievements, obstacles and the future. BULLET: Jurnal Multidisiplin Ilmu. 2023; 2 (2): 548–557.

3. Chiryapkin A.S. Obzor proizvodnykh pirimidina kak farmakologicheski aktivnykh soedinenii. Juvenis scientia. 2022. 8 (5): 16–30. doi: https://doi.org/10.32415/jscientia_2022_8_5_16-30. EDN: CFSWFH (in Russian)]

4. Zarenezhad E., Farjam M., Iraji A. Synthesis and biological activity of pyrimidine-containing hybrids: emphasis on pharmacological application. Journal of Molecular Structure. 2021; 1230: 129833. doi: 10.1016/j.molstruc.2020.129833.

5. Tyurenkov I.N., Tsibizova A.A., Samotrueva M.A., Ozerov A.A. Immunotropnye svoistva karbonil'nogo proizvodnogo khinazolina. Astrakhanskii Meditsinskii Zhurnal. 2017; 12 (2): 81–88. (in Russian)]

6. ELkanzi N. A. Synthesis and biological activity of some pyrimidine derivatives: a review. Oriental Journal of Chemistry. 2020; 36 (6): 1001. doi: https://doi.org/10.13005/OJC/360602.

7. Ahmed K., Choudhary M. I., Saleem R.S.Z. Heterocyclic pyrimidine derivatives as promising antibacterial agents. Eur J Med Chem. 2023; 259: 115701. doi: 10.1016/j.ejmech.2023.115701.

8. Andrews B., Komati K., Mohan S. Synthesis and comparison of the antibacterial activity of pyrimidine derivatives. Journal of Chemical Sciences 2017; 129: 335–341. doi: 10.1007/s12039-017-1228-z.

9. Hmidet A., Yasenyavskaya A.L., Tsibizova A.A., Tyurenkov I.N., Ozerov A.A., Samotrueva M.A. Evaluation of the antimicrobial activity of pyrimidine compound 3-(2-benzyloxy2-oxoethyl)quinazoline-4(3H)-oh in relation to Klebsiella pneumoniae. Antibiot Khimioter = Antibiotics and Chemotherapy. 2023; 68 (1–2): 22–26. doi: https://doi.org/10.37489/0235-2990-2023-68-1-2-22-26. (in Russian)]

10. Tsibizova A.A., Yasenyavskaya A.L., Tyurenkov I.N., Ozerov A.A., Samotrueva M.A. Otsenka protivomikrobnoi aktivnosti pirimidinovogo soedineniya 2-metil-3-(2-fenil-2-oksoetil)khinazolin-4(3h)-on v otnoshenii Klebsiella pneumoniae v usloviyakh in vivo. Sibirskii Zhurnal Klinicheskoi i Eksperimental'noi Meditsiny. 2023. 38 (1): 175–180. doi: https://doi.org/10.29001/2073-8552-2023-38-1-175-180 (in Russian)]

11. Starikova A.A., Gabitova N.M.K., Tsibizova A.A., Ozerov A.A., Tyurenkov I.N., Bashkina O.A. i dr. Izuchenie antimikrobnoi aktivnosti novykh proizvodnykh khinazolin-4(3n)-ona po otnosheniyu k Echerichia coli i Klebsiella pnevmoniae. Astrakhanskii Meditsinskii Zhurnal. 2022; 17 (1): 60–71. (in Russian)]

12. Mahasenan K.V., Molina R., Bouley R., Batuecas M.T., Fisher J.F., Hermoso J.A. et al. Conformational dynamics in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, allosteric communication network and enablement of catalysis. J Am Chem Soc. 2017; 139 (5): 2102–2110. doi: 10.1021/jacs.6b12565.

13. Mahato A., Shrivastava B., Shanthi N. Synthesis, molecular docking and biological evaluation of substituted quinazolinones as antibacterial agents. Chemical Science Transactions. 2015; 4 (2): 595–603. doi: https://doi.org/10.7598/cst2015.995.

14. Fan Z., Li Yu., Jin Yu., Li H., Lu Yu. J., Yan S. K. et al. Antibacterial activity and mechanism of action of thio phenyl substituted pyrimidine derivative. RSC Adv. 2019; 9 (19): 10739–10744. doi: 10.1039/C9RA01001G.